The Menopause Society

"A photo of multiple different sex toys".

A recent study looked at sex-toy use during partnered sex and masturbation in older adult women.

Read more at tinyurl.com/mtxuyh8u.

#sexualhealth #masturbation #orgasm #midlife

The Menopause Society logo and Leading the Conversation tagline with text reading "Are there different indications for the use of systemic and vaginal estrogen?".

"Q: Are there different indications for use of systemic & vaginal estrogen? Yes. Low-dose vaginal estrogen is used for managing genitourinary symptoms, such as vulvovaginal dryness, itching, irritation, & pain with sexual activity, along with urinary symptoms of urgency and frequency. There are also data suggesting that it reduces the risk of urinary tract infections in postmenopausal women. Systemic estrogen is US-gov't approved for management of vasomotor symptoms & prevention of bone loss & may have some beneficial effects for sleep & mood. Systemic estrogen may also be effective for managing genitourinary symptoms, but the use of low-dose vaginal estrogen is preferred in women who are only experiencing these symptoms. For women on systemic HT who continue to experience genitourinary symptoms, the addition of local, low-dose estrogen may be needed. References: The 2022 HT Position Statement of The Menopause Society Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline".

Question: Are there different indications for the use of systemic and vaginal estrogen?

Yes. See the second graphic for details. #hormonetherapy #menopause

References:
tinyurl.com/22v85s8f
tinyurl.com/y5k6b3py

The Menopause Society logo and Leading the Conversation tagline with text reading "Are there benefits to starting hormone therapy before menopause onset?".

"Question: Are there benefits to starting hormone therapy before menopause onset? No. There is no data to support the use in perimenopause to “prevent” menopause or chronic disease. Although hormone therapy can be used for symptom management in perimenopause, it is not a high-enough dose to prevent pregnancy or to control heavy menstrual bleeding. It can be used in combination with a progestin-containing intrauterine device that does provide contraception. Alternatively, a low-dose hormone contraceptive pill/patch/ring may also be an option for contraception, management of heavy menstrual bleeding, and symptom management in perimenopausal women. Reference: Practice Pearl: Contraception in Perimenopause".

Q: Are there benefits to starting #hormonetherapy before #menopause onset?
A: No. There is no data to support the use of HT in #perimenopause. Although #hormonetherapy can be used for symptom management in perimenopause, it is not a high-enough dose to prevent pregnancy or to control heavy bleeding.

The Menopause society logo and leading the conversation tagline with text reading "should hormone therapy be used for weight loss?".

"Question: Should hormone therapy be used for weight loss? No. Hormone therapy has favorable effects on body composition but typically does not result in weight loss. There is a link between adiposity and menopause symptoms. Adiposity, and particularly central adiposity, is associated with increased vasomotor symptom severity. Although weight loss via lifestyle intervention has been associated with decreased frequency and severity of vasomotor symptoms, the effect of weight loss medications on vasomotor symptoms is limited. There is preliminary evidence that hormone therapy use may augment response to weight loss medications, but additional study is needed before this can be recommended as standard practice in clinical care. References: The 2022 Hormone Therapy Position Statement of The Menopause Society Practice Pearl: Pharmacologic Options for the Treatment of Overweight and Obesity".

Question: Should hormone therapy be used for weight loss?

No. Hormone therapy has favorable effects on body composition but typically does not result in weight loss. See more in second image.

#hormonetherapy #weight #menopause

Graphic is The Menopause Society logo and Leading the Conversation tagline and text reading " I am in my 60s. Is it too late to start hormone therapy?".

Question: I am in my 60s. Is it too late to start hormone therapy? It depends. There is nothing magic about the age of 60 with regard to starting hormone therapy. More important are time since menopause, with risks being lower in women who are within 10 years of menopause onset, existing contraindications, risk factors for cardiovascular disease and breast cancer, and reasons for initiating hormone therapy (eg, bone protection, hot flash management). Hormone therapy should not be used for prevention of heart disease, dementia, or aging in general. Shared decision-making between women and their clinicians is essential, because these discussions are often nuanced. References: The 2022 Hormone Therapy Position Statement of The Menopause Society The Menopause Society Statement on Hormone Therapy Misinformation

Question: I am in my 60s. Is it too late to start #hormonetherapy?

It depends. Shared decision-making between women and their clinicians is essential, because these discussions are often nuanced. See second image for more information.

References:
tinyurl.com/22v85s8f
tinyurl.com/ydwttjkv

Graphic is The Menopause Society logo and Leading the Conversation tagline and text reading "does hormone therapy prevent bone loss and protect against fracture risk?".

"Question: Does hormone therapy prevent bone loss and protect against fracture risk? Yes. Hormone therapy is US-government approved for prevention of bone loss and can be used for this purpose in women who do not have contraindications and who are appropriate candidates. Hormone therapy prevents bone loss and reduces fracture risk in healthy, postmenopausal women, with dose-related effects on bone density. Hormone therapy is not US-government approved for treatment of osteoporosis, and other management strategies should be considered in women with osteoporosis. Stopping hormone therapy results in initial rapid bone loss and potentially in transiently increased fracture risk with longer-term protection. Unless contraindicated, women with premature menopause should use hormone therapy to prevent bone loss and reduce fracture risk until the average age of menopause when treatment may be reassessed. References: The 2022 Hormone Therapy Position Statement of The Menopause Society Discontinuation of Menopausal Hormone Therapy and Risk of Fracture".

Does #hormonetherapy prevent bone loss and protect against fracture risk?

Yes. HT is US-government approved for prevention of #boneloss and can be used for this purpose in appropriate candidates who do not have contraindications.
References: tinyurl.com/22v85s8f tinyurl.com/35kf8h8v

#hormonetherapy #menopause #dementia #cognition

"Graphic with The Menopause Society logo and tagline Leading the Conversation along with text reading 'Should hormone therapy be used to prevent dementia?'".

"Question: Should hormone therapy be used to prevent dementia? No. Hormone therapy is not recommended for prevention or treatment of cognitive decline or dementia. At the present time, we do not have evidence that the use of hormone therapy in women undergoing menopause at the usual age prevents dementia. It may have cognitive benefits when started in women after hysterectomy and oophorectomy before menopause onset. The risk of dementia was increased in women aged older than 65 years who initiated conjugated equine estrogens plus medroxyprogesterone acetate in the Women’s Health Initiative Memory Study. Reference: The 2022 Hormone Therapy Position Statement of The Menopause Society".

Question: Should hormone therapy be used to prevent dementia?

No. #Hormonetherapy is not recommended for prevention or treatment of cognitive decline or #dementia.

Reference: The 2022 Hormone Therapy Position Statement of The Menopause Society available at tinyurl.com/22v85s8f. #menopause

"Question: Should hormone therapy be used to prevent heart disease? No. Hormone therapy is not recommended for primary or secondary prevention of cardiovascular disease. The effects of hormone therapy on coronary heart disease (CHD) vary depending on when it is initiated in relation to time since menopause and age. In younger women who are within 10 years of menopause onset, there is a favorable effect on CHD and all-cause mortality that needs to be considered against potential rare increases in risks of breast cancer, venous thromboembolism, and stroke. Women who initiate hormone therapy 20 to 30 years after the onset of menopause are at higher risk of coronary heart disease, venous thromboembolism, and stroke than women initiating hormone therapy early in menopause. Reference: The 2022 Hormone Therapy Position Statement of The Menopause Society".

"Graphic with The Menopause Society logo and tagline Leading the Conversation along with text reading 'Should hormone therapy be used to prevent heart disease?'".

Should hormone therapy be used to prevent #heartdisease?

No. #Hormonetherapy is not recommended for primary or secondary prevention of #cardiovasculardisease.

Reference: The 2022 Hormone Therapy Position Statement of The Menopause Society available at tinyurl.com/22v85s8f

#menopause

REMINDER: This is scheduled for this week!

US health leaders hailed the benefits of hormone therapy for menopause. Doctors are pushing for balance | CNN Experts say FDA officials and doctors should treat hormone therapy like any other drug that has both benefits and risks, and remember that hormones aren’t the only options for treating menopausal symp...

www.cnn.com/2025/11/12/h...

#menopause #hormonetherapy

"A woman lies in bed looking at an alarm clock displaying the time of 3:35".

A new study suggests sleep-related disorders in postmenopausal women may increase their risk of hypertension. #menopause #sleepdisorders #postmenopause #hypertension

tinyurl.com/td8kwxs3

"Doctors Nanette Santoro and Andrew Kaunitz, the Menopause step-by-step webinar series logo and text reading 'Perimenopause: Addressing symptoms and contraceptive needs'".

Members, please join us on Wed, Nov 19, for the next Step-by-Step webinar. Dr Nanette Santoro and Dr Andrew Kaunitz will discuss “Perimenopause: Addressing Symptoms and Contraceptive Needs.” Register in the Member Center on our website. It will also be recorded and posted in the Member Center.

"A middle aged woman wraps a tape measure around her waist."

A new study suggests an excessive accumulation of fat in the abdominal area is a risk factor for domain-specific cognitive decline.

For more information see tinyurl.com/5n6w55vf.

#KEEPS #menopause #estrogen #weight #cognition

"The Menopause Society OnDemand shown on a smart phone".

Missed The Menopause Society Annual Meeting? Access the recorded presentations anytime, anywhere. menopause.ondemand.org.

#menopauseeducation #menopauseresearch

Doctors Cheryl Cox Kinney, Makeba Williams, Laurie Jeffers, and Carolyn Gibson.

The Menopause Society announces new officers: President Dr Cheryl Cox Kinney, President-Elect Dr Makeba Williams, Treasurer Dr Laurie S Jeffers, and Secretary Dr Carolyn Gibson.

Doctors Emily Lau and Jill Liss.

Congratulations to the following who were newly elected to The Menopause Society's Board of Trustees!

Emily Lau, MD, MPH
Jill Liss, MD, MSCP, FACOG

The Menopause Society logo with text reading 2025 Poster Prize Winners and photo of Doctor Liane Hunter with the heading “First Place” surrounded by photos of Doctor Anna Caroline Cochrane and Doctor Pauline Maki.

Congratulations to this year's Poster Prize Winners!

First place went Dr Liane Hunter from Brigham and Women's Hospital and Harvard Medical School.

The two runner-up prizes went to Dr Anna Caroline Cochrane from Wake Forest University and Dr Pauline Maki from University of Illinois Chicago.

Reminder, Open Access is available through November 1!

The Menopause 2025 Annual Meeting October 21-25, 2025, Hyatt Regency, Orlando, Saturday at a glance: Impact of Alcohol on Health Outcomes, Vasomotor Symptom Management, Androgens, Query the Experts.

Today at Menopause meeting: Impact of Alcohol on Health Outcomes, Vasomotor Symptom Management, Androgens, Query the Experts.

Recorded sessions will be available on OnDemand at menopause.ondemand.org.

#menopauseeducation #androgens #vasomotorsymptoms

The Menopause 2025 Annual Meeting October 21-25, 2025, Hyatt Regency, Orlando, Thursday at a glance: Bioengineering Personalized Human Hearts, Cardiovascular Health, Breast Health, Menopause in Special Populations, Vulvar Health, and Top-Scoring Concurrent Abstract Presentations.

Today at Menopause meeting: Bioengineering Human Hearts, Cardiovascular Health, Breast Health, Menopause in Special Populations, Vulvar Health, and Abstract Presentations.

Recorded sessions will be available on OnDemand at menopause.ondemand.org.

#menopauseeducation #menopauseresearch

Healthcare professionals from multiple backgrounds stand together.

The Menopause Society receives $5 million from the Steven & Alexandra Cohen Foundation to forward the digital-innovation phase of its NextGen Now Initiative. The grant will help create a robust digital ecosystem designed to transform and scale #menopauseeducation and training.

The Menopause 2025 Annual Meeting October 21-25, 2025, Hyatt Regency, Orlando, Thursday at a glance: Reframing longevity and extending health span in women, weight, bone health, progestogens, vulvar health, concurrent abstract presentations.

Today at The Menopause Society meeting: Reframing Longevity and Extending Health Span in Women, Weight, Bone Health, Progestogens, Vulvar Health, and Concurrent Abstract Presentations.

Recorded sessions available on OnDemand at
menopause.ondemand.org.

#menopauseeducation #menopauseresearch

A graph of The Menopause Society Membership Statistics shows growth from 2,276 members in 2019 to 12,000 in 2025.

The Menopause Society is experiencing phenomenal growth!

We invite you to join us in advancing women's health and healthcare experiences during the menopause transition and beyond.

menopause.org/become-a-mem...

Graphic with text that says 'The 2025 Annual Meeting Society October 21-25, 2025 Hyatt Regency, Orlando Wednesday At a Glance ·Opening Symposium- Perimenopause Menopause Research Session Test Your Women's Health Knowledge Presidential Symposium 1-Mind, Brain, and Body Connections'.

Today at The Menopause Society meeting: #Perimenopause, #MenopauseResearch, Test Your Women’s Health Knowledge interactive session, and the Presidential Symposium on Mind, Brain, and Body Connections.

Recorded sessions will be available on OnDemand at menopause.ondemand.org.

#menopauseeducation

Graphic of The Menopause Society 2025 Annual Meeting banner and text reading "Tuesday at a glance, menopause 101 course, sexual health 101 course".

The #Menopause101 course reviews menopause basics and an evidence-based framework for managing menopause signs and symptoms.

The #SexualHealth 101 course reviews diagnosis of sexual problems, treatments, and more.

View menopause.ondemand.org/.

#menopauseeducation

Graphic with the menopause society logo and text reading "Open access until November 2, Menopause step-by-step Role of progestogens in hormone therapy".

In recognition of #WorldMenopauseDay on Oct 18, the editors of the #MenopauseStepbyStep series have arranged for open access to the Oct article, The Role of #Progestogens in #HormoneTherapy. #menopauseeducation

This is free to all on the Menopause Journal site until Nov 2. tinyurl.com/y6yh3t6h

Graphic with text reading "annual meeting in person registration is sold out! virtual meeting OnDemand registration is open!" and The Menopause Society logo.

Reminder: The Menopause Society’s 2025 Annual Meeting, with the theme of Optimizing Health and Longevity at Menopause and Beyond, is available virtually through OnDemand!

View The Scientific Program at tinyurl.com/bdd3eh6y. Register for OnDemand at menopause.ondemand.org.

#menopauseeducation

REMINDER: This is this week!